Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 18INDUSTRY 7NIH 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 25Rectal Neoplasms 21Colonic Neoplasms 11Esophageal Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 5Adenocarcinoma Of Esophagus 5Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Rhabdoid Tumor 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Lung Neoplasms 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastro Oesophageal Cancer 1Fibrolamellar hepatocellular carcinoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Breast Neoplasms 1

Interventions

Ultrasonography 1Preoperative Exercise 1Oxaliplatin 1Leucovorin 1Fluorouracil 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gastrointestinal Neoplasms × Oxaliplatin × Clear all
NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡